Rocket Pharmaceuticals, Inc. Common Stock (RCKT) Stock Price, Quote & AI Analysis

Live RCKT stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Rocket Pharmaceuticals, Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Rocket Pharmaceuticals, Inc. Common Stock (RCKT), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

RCKT
Rocket Pharmaceuticals, Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
3.445000
High
3.625000
Low
3.380000
Volume
1,349,532
VWAP
-
Market Cap
$387,435,576.24
52W Range
$2.19 - $11.45
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 25, 2026 Q4
After Hours
EPS Estimate: $-0.4496
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Rocket Pharmaceuticals, Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Rocket Pharmaceuticals, Inc. Common Stock Overview

Company information

Company Overview

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.

Company Details
Market Cap
$375.53M
Shares Outstanding
108,222,230
Weighted Shares Outstanding
108,222,228
CEO
Gaurav D. Shah
Address
350 FIFTH AVENUE, NEW YORK, NY, 10118
Employees
299
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Rocket Pharmaceuticals, Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...